Cost-Effectiveness of Canal Wall Up Tympanoplasty With and Without Obliteration in Cholesteatoma Surgery.

Authors

Tom R von Hebel, Martijn A H Oude Voshaar, Steven W Mes, Bernd Kremer, Robert J Pauw, Hylke F E van der Toom

Published in

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. Oct 29, 2026. Epub Oct 29, 2026.

Abstract

To determine the cost-effectiveness of the bony obliteration tympanoplasty compared with canal wall up without obliteration in cholesteatoma surgery from a healthcare payer perspective.
State-transition Markov model.
Tertiary care center in the Netherlands.
A state-transition Markov model was developed to evaluate costs and health outcomes over a 5-year time horizon. Health benefits were quantified in quality-adjusted life years. All costs were expressed in euros. Transition probabilities and complication rates were derived from a propensity score-matched retrospective cohort study (n = 110 ears). Matching variables included cholesteatoma origin, disease extent according to the STAM classification, and prior middle ear surgery. Deterministic one-way sensitivity analyses and probabilistic sensitivity analyses were conducted.
The model estimated 5‑year costs and health outcomes for a 40‑year‑old patient undergoing either bony obliteration tympanoplasty or the canal wall up technique without mastoid obliteration. Bony obliteration tympanoplasty resulted in higher mean costs (€5954 vs €4844), mainly driven by longer operative time. However, it also yielded more quality-adjusted life years over 5 years (2.76 vs 2.47). This corresponded to an incremental cost-effectiveness ratio of €3855 per additional quality-adjusted life year gained, which is well below commonly accepted willingness-to-pay thresholds. Probabilistic sensitivity analysis confirmed the robustness of these findings, indicating that bony obliteration tympanoplasty is cost-effective in 97% of simulations at a willingness-to-pay of €50,000.
Bony obliteration tympanoplasty is a cost-effective alternative to the canal wall up technique without mastoid obliteration for cholesteatoma surgery and should be considered in surgical planning.

PMID:
42958869
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.